Florham Park-based biopharmaceutical company Protalex announced Thursday it has completed a private placement financing in the amount of $2.82 million.
According to the announcement, the placement accredited investors in the form of 471,334 shares of common stock at $6 per share. Proceeds of the financing will be used for working capital purposes, principally to fund ongoing clinical trials and studies and related activities.
Like NJBIZ on Facebook: facebook.com/NJBIZ
Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.View Comment Policy